Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline M Hull

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Discovery|May 26, 2021
Approaches for refining and furthering the development of CAR-based T cell therapies for solid malignanciesCaroline M Hull, John Maher
Expert Opinion on Biological Therapy|May 1, 2019
Novel approaches to promote CAR T-cell function in solid tumorsCaroline M Hull, John Maher
Diabetologia|August 4, 2017
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?Caroline M Hull, Mark Peakman, Timothy I M Tree
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2024
Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent mannerCaroline M Hull, Daniel Larcombe-Young, Roberta Mazza, et al.
Journal of Autoimmunity|January 25, 2017
Generation of human islet-specific regulatory T cells by TCR gene transferCaroline M Hull, Lauren E Nickolay, Megan Estorninho, et al.
Frontiers in Immunology|September 20, 2021
Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects <i>via</i> Adult Progenitor Cell Co-CultureJames L Reading, Valerie D Roobrouck, Caroline M Hull, et al.
Cell Reports. Medicine|November 20, 2024
Solid tumor immunotherapy using NKG2D-based adaptor CAR T cellsJana Obajdin, Daniel Larcombe-Young, Maya Glover, et al.
Cell Reports. Medicine|January 14, 2022
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptorsTamara Muliaditan, Leena Halim, Lynsey M Whilding, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|May 26, 2021
Approaches for refining and furthering the development of CAR-based T cell therapies for solid malignanciesCaroline M Hull, John Maher
Expert Opinion on Biological Therapy|May 1, 2019
Novel approaches to promote CAR T-cell function in solid tumorsCaroline M Hull, John Maher
Diabetologia|August 4, 2017
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?Caroline M Hull, Mark Peakman, Timothy I M Tree
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2024
Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent mannerCaroline M Hull, Daniel Larcombe-Young, Roberta Mazza, et al.
Journal of Autoimmunity|January 25, 2017
Generation of human islet-specific regulatory T cells by TCR gene transferCaroline M Hull, Lauren E Nickolay, Megan Estorninho, et al.
Frontiers in Immunology|September 20, 2021
Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects <i>via</i> Adult Progenitor Cell Co-CultureJames L Reading, Valerie D Roobrouck, Caroline M Hull, et al.
Cell Reports. Medicine|November 20, 2024
Solid tumor immunotherapy using NKG2D-based adaptor CAR T cellsJana Obajdin, Daniel Larcombe-Young, Maya Glover, et al.
Cell Reports. Medicine|January 14, 2022
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptorsTamara Muliaditan, Leena Halim, Lynsey M Whilding, et al.
Pageof 1